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Abstract
Allelic specific gene expression (ASGE) appears to be an important factor in human phenotypic variability and as a
consequence, for the development of complex traits and diseases. In order to study ASGE across the human genome, we
have performed a study in which genotyping was coupled with an analysis of ASGE by screening 11,500 SNPs using the
Mapping 10 K Array to identify differential allelic expression. We found that from the 5,133 SNPs that were suitable for
analysis (heterozygous in our sample and expressed in peripheral blood mononuclear cells), 2,934 (57%) SNPs had
differential allelic expression. Such SNPs were equally distributed along human chromosomes and biological processes. We
validated the presence or absence of ASGE in 18 out 20 SNPs (90%) randomly selected by real time PCR in 48 human
subjects. In addition, we observed that SNPs close to -but not included in- segmental duplications had increased levels of
ASGE. Finally, we found that transcripts of unknown function or non-coding RNAs, also display ASGE: from a total of 2,308
intronic SNPs, 1510 (65%) SNPs underwent differential allelic expression. In summary, ASGE is a widespread mechanism in
the human genome whose regulation seems to be far more complex than expected.
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Introduction
Allelic-specific gene expression (ASGE) or allelic imbalance
appears to be an important factor for human phenotypic
variability and as a consequence, for the development of common
diseases [1]. Traditionally, ASGE has been associated with the
phenomena of X-chromosome inactivation and genomic imprint-
ing [2]. However, several recent studies have emphasized the
extent to which gene expression varies within and between
populations [3,4,5,6], and it is now clear that ASGE is relatively
common among non-imprinted autosomal genes [7,8,9]. Further-
more, certain genes display allelic variation in gene expression that
is transmitted by Mendelian inheritance and this variation may be
linked to common human disorders [8,10,11].
Variation in gene expression may result from changes in the
sequence of regulatory elements, such as single nucleotide
polymorphisms (SNPs), and recent surveys indicates that this
phenomenon is widespread through the genome and tissues
[3,12,13,14]. Such changes may explain up to 25 to 35% of the
interindividual differences in allelic gene expression [15,16].
Hence, identification and characterization of ASGE will help us
to appreciate the extent of functionally important regulatory
variation. In turn, this will enable us and to focus on candidate
haplotypes whose allelic differences in expression may provide an
important link between individual genetic variation and complex
traits or common diseases.
In order to study ASGE across the human genome, we have
performed a study in which genotyping was coupled with an
analysis of allele-specific gene expression by screening 11,560
SNPs using the Mapping 10 K Array (Affymetrix) to identify
differential allelic expression. We found that ASGE is very
common in the human genome and that it is widespread in many
biological processes. We validated our findings using a new cohort
of 48 subjects. In addition, we observed that SNPs close to -but not
included in- segmental duplications had increased levels of ASGE
and we assessed the effect of copy number variation (CNV) using a
44 K Agilent probe array in the same individuals. Finally, we
found that transcripts of non-coding RNA (ncRNA) also display
allelic imbalance.
Results
Allele-specific expression screening
Because we screened for ASGE in peripheral blood mononu-
clear cells (PBMCs), SNPs suitable for analysis had to meet the
following criteria: (1) at least one individual was heterozygous for
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4150the SNP; and (2) the transcript containing the SNP is expressed in
PBMCs. We screened 20 individuals founding at least one
heterozygous individual for 10,837 SNPs out of the 11,560 SNPs
in the 10 K Mapping Array. Of these SNPs, 5,133 corresponded
to transcripts expressed in PBMCs (see Methods). Thus, these
5,133 SNPs constitute the analyzed in this study. After the
significance was established, the ASGE ratio was considered
significant if it was bigger than 1.37 or smaller than 0.81. We
found that 2,934 out of 5,133 (57%) SNPs were subject to allelic
imbalance: 2,235 SNPs (76%) had a ratio between the expression
intensity of the two alleles lower than two, 476 SNPs (16%)
displayed a ratio between two- and threefold, and for 223 SNPs
(8%) the ratio was greater than a threefold excess for at least one
individual. In contrast, 2,199 SNPs (43%) did not display
significantly different levels of expression between the two alleles.
A complete list of all the SNPs studied and their characteristics can
be found in the Supplementary Table S1.
As predicted, in female, the percentage of SNPs with
differentially expressed alleles on the X chromosome was
significantly higher (Chi-square test, p,0.001) than on autosomic
chromosomes since genes subject to X-chromosome inactivation
are expected to display skewed allelic expression [17]. Indeed, we
were able to identify five known imprinted genes that met the
criteria established for the analysis of allelic expression: KCNQ1,
MEG3, PPP1R9A, SLC22A3 and SLC22A23. We confirmed
ASGE for the first four (Table 1).
In order to validate the results of the Mapping 10 K Array
experiments, we performed allele-specific quantitative PCR for 20
SNPs randomly selected in forty-eight new subjects. The results of
the real-time quantitative PCR validated the results of the
screening since we confirmed the allele-specific or non allele-
specific expression in 18 of these 20 SNPs (90%; Table 2),
suggesting a low false positive discovery rate. These results validate
our experimental method as well as our sample handling and
processing.
Allele-specific expression is widespread across the
human genome and in different biological processes
We mapped the SNPs that displayed ASGE to chromosomes in
order to look for regions in the human genome with a higher
density of such SNPs (Table 3 and Figure 1). When the SNP
distribution in each chromosome was analyzed, we found that an
average of 57% of the SNPs per chromosome displayed ASGE,
the same percentage as for the overall genome, and without any
chromosome deviating significantly from this percentage. This is
further evidence that ASGE is widespread across the human
genome. Furthermore, the ‘‘SNP proximity’’ test (see Methods)
was used to search for clusters of differentially expressed allelic
SNPs. As a result, we found a total of 133 clusters dispersed
throughout the genome with a median of 4 SNPs per cluster (rank
1–36). Localization, length and p-value of clusters can be found in
Supplementary Table S2.
The subset of 5,133 SNPs studied corresponded to a total of
1,632 known genes, 1,195 of which displayed allelic imbalance in
at least one of their SNPs (73%). In order to assess whether ASGE
is more influential in any given biological process, we assessed the
distribution of genes that did or did not display differential allele
expression in the Gene Ontology (GO) database (www.geneontol-
ogy.org). The comparison between the distributions of genes
among different biological processes (GO terms present in levels 3
to 9) did not demonstrate any significant differences (Supplemen-
tary Table S3). Thus, the genes subject to differential allelic
expression appear to participate in a wide range of different
biological processes.
Allele-specific gene expression in ncRNA
We also focused our analysis on the recently described
transcripts of ncRNA, previously named transcripts of unknown
function, that introduce more complex strategies for transcrip-
tional regulation than previously anticipated [18,19]. Eukaryotic
genes contain clearly identifiable open reading frames (ORFs) that
direct the translation of functional proteins. However, not all RNA
transcripts (other than tRNA, rRNA or snRNA) are translated into
polypeptides. Many non-translatable mRNA-like RNA transcripts
have been found in the cell. They are polyadenylated, spliced and
are lacking long ORFs [20]. In this work, ncRNA are defined as
non-coding polyadenylated RNAs that are transcribed but for
which there is no functional information. Like eukaryotic
messenger RNA, ncRNA contain poly-A tails and thus, they are
represented among cDNAs synthesised from mature RNAs using
an oligo(dT) primer (see Methods). Adopting this strategy, we
measure allele specific expression only of exonic SNPs because,
other RNA molecules such as immature RNA that contain introns,
are not represented. Surprisingly, in the subset of the 5,133
heterozygous SNPs expressed in PBMCs, a total of 2,311 (45%)
and 2,455 (48%) SNPs were intronic and intergenic respectively
(Table 4). Of the intronic SNPs, 1,511 (65%) underwent
differential allelic expression, as well as 1,190 (48%) of the
intergenic SNPs. This result is consistent with the high levels of
unannotated transcription detected [18,19] and it also shows that
like known genes, ncRNA display ASGE. We validated ASGE in
intronic and intergenic SNPs by real-time quantitative PCR in 18
Table 1. Differential allele expression ratios for imprinted genes.
Imprinted gene dbSNP RS ID Alleles Location
ASGE
(p,0.01) ASGE ratio
No. of individuals
studied
Percent of individuals
studied with ASGE
KCNQ1 rs63934 C+/T 11p15.5 Yes 1,7661,06 8 63%
MEG3 rs721910 A/C 14q32.2 No 1,23 1 —
MEG3 rs721909 A+/G 14q32.2 Yes 1,3860,41 2 50%
PPP1R9A rs2374983 A+/G 7q21.3 Yes 1,49 1 100%
SLC22A23 rs4128536 A/G 6p25.2 No 1,00 1 —
SLC22A23 rs4128535 A/G 6p25.2 No 1,0560,07 2 —
SLC22A3 rs2174914 C/G+ 6q25.3 Yes 1,2960,44 7 29%
Results are presented as the mean6SD. Values are the ratios (Allele 1/Allele 2) between the two alleles. The values were inverted if less than one (Allele 2/Allele 1, when
Allele 2 was preferentially expressed). The preferentially expressed allele is labelled with ‘‘+’’.
doi:10.1371/journal.pone.0004150.t001
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result of the presence of contaminants such as DNA in the RNA
samples after the DNase digestion, we used RNA as template for
the quantitative real-time PCR under the same conditions used in
the validation experiments. All samples were checked for one
intronic SNP without finding any amplification (data not shown).
Allele-specific expression is dependent on regulatory
effects associated to segmental duplications
A potential cause of ASGE might be the considerable variation
in gene copy number in the human genome [21]. If individuals
have different copies of a given duplicon in homologous
chromosomes, that is, if they are heterozygous for structural
variants and these structural variants contain genes, it is possible
that certain alleles appear to be differentially expressed. This
differential expression may result simply because they are present
in different copy numbers in different chromosomes and not
through any regulatory effects. To test this hypothesis, we
examined whether the location of a SNP within known structural
variants (SDs or CNVs) might affect the probability that it were
differentially expressed. As a first test, we used the location of SDs
that can be found in public databases (see Methods). Only 106 of
the SNPs in our study mapped within known segmental
duplication regions and a test showed that SNPs presenting
ASGE are not more likely to be located inside SDs than SNPs
without ASGE (Table 5), even if the lack of statistical significance
may be an effect of small sample size, as we will see below.
Another potential cause of ASGE is heterozygosity among cis-
regulatory elements. In particular, SDs may contain cis-regulatory
elements that affect the expression of nearby genes. If this were a
frequent phenomenon, allelic variation in gene expression should
be more frequent in single-copy regions that are located in the
vicinity of SDs than in single-copy regions far away from
duplicons. Using the same dataset than above, we observed that
SNPs with ASGE are more frequent near SDs. This enrichment in
SNPs with ASGE is especially strong in the 10 Kb windows
around SD regions (Table 5). The effect decreases in more distant
(non overlapping) windows.
As a second series of tests, we computed the average ratios of
allele expression instead of the proportion of SNPs presenting
ASGE. Results are presented in Table 6. Interestingly, although
the proportion of SNP with and without ASGE located inside SDs
were not significantly different, SNPs inside SDs have on average a
higher ratio of allele expression. This effect, again, decreases with
distance to the SD. This means that the closest a SNP is to a
segmental duplication, the strongest the degree of allele specific
gene expression, probably because of regulatory effects attribut-
able to SDs. The maximum effect is registered in SNPs located
within SDs, which are probably present in different copy numbers
in different chromosomes.
We then used information about known Copy Number Variants
(CNV; dbCNV database, see Methods). Similar analyses provide
consistent, even if slightly different results. In particular, there are
more SNPs with ASGE inside CNVs (Table 7), but these SNPs do
not present a higher ratio of gene expression (Table 8). Unlike
SNPs near SDs, SNPs within 10 Kb of a CNV do not present any
significant effect, probably because of small sample size, since the
effect is stronger in the 100 kb window.
Because there is high inter-individual variability in CNV and
SD content [22], it is possible that some genome regions that
contain CNVs or SDs in public databases are in fact single-copy in
the individuals included in our study. To try to overcome this
problem we studied CNVs in the tested individuals. We used the
Agilent 44 K array to create the indCNV dataset, where
individual CNV patterns can be associated to the corresponding
individual ASGE patterns (see Methods). In this analysis, we
retrieve the same trend that we reported above. In table 9, we see
that there are more SNPs with ASGE close to the CNVs detected
in the studied individuals than far away from these CNVs.
However, this effect is not significant. Since the number of CNVs
detected in each individual is much lower than the total of SDs
and CNVs present in databases, we suggest that, sample size, and
thus statistical power, in the vicinity of CNVs is very small.
Discussion
In this study, we have used high throughput screening of 11,500
SNPs to detect ASGE across the human genome. Our study
indicates that allelic variation in gene expression is widespread
across the human genome and in different biological processes,
including systems of transcriptional regulation. We found that the
57% of human SNPs studied here undergo allelic imbalance and
that these SNPs are distributed proportionally among chromo-
somes. Indeed, among different biological processes we did not
find any difference in the distribution of genes that displayed
Table 3. Distribution of differentially expressed alleles of
SNPs across chromosomes (assembly March 2006; chr. Y not
included).
Chr
No. of SNPs
available for
analysis
Differentially
expressed SNPs
% differentially
expressed SNPs
No.
Clusters*
1 405 250 62 4
2 459 271 59 3
3 397 231 58 9
4 339 168 50 4
5 343 198 58 12
6 362 229 63 5
7 273 154 56 3
8 257 141 55 3
9 239 138 58 36
10 284 165 58 5
11 271 149 55 5
12 253 138 55 6
13 196 90 46 2
14 196 111 57 1
15 149 85 57 4
16 117 59 50 1
17 89 58 65 1
18 126 63 50 1
19 52 34 65 15
20 112 80 71 5
21 86 47 55 3
22 38 23 61 4
X4 2 2 4 5 7 1
No
mapped
48 28 58 –
*See Figure 1.
The total No. of SNPs mapped was 5,085 of the 5,133 found in the screening
due to the fact that there is no annotation for 48 studied SNPs.
doi:10.1371/journal.pone.0004150.t003
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present in several tissues [21], indicating that this is a common
mechanism of genomic regulation for many pathways and cell
types. Indeed, ASGE is also implicated in a variety of disease states
[23].
Thus, an interesting question that arises is how this ASGE is
controlled. A potential cause is the variation in copy number
within the human genome [21]. To test for this possibility we
examined whether the probability of an SNP undergoing
differential allelic expression changes if the SNP is located within
SDs or CNVs described in public databases. We found that only a
small percentage of the SNPs displaying differentially allele
expression were included in these structural variants. However,
the proportion of SNPs with differentially expressed alleles was
higher in SNPs close to SDs, or within CNVs, suggesting that
regulatory elements may lie within these genomic duplications.
Moreover, SNPs inside SDs have higher ratio of ASGE, suggesting
regulatory effects linked to SDs. Therefore, the relationship
between structural variation and ASGE, detected both in variation
in intensity and presence/absence of allelic expression, seems to be
rather complex. We also studied the contribution of individual
CNVs to allelic imbalance, but results of the analysis were not
Figure 1. Chromosome mapping of heterozygous SNPs expressed in PBMCs. The position of each SNP on the chromosome is based on the
annotation in dbSNP (version 126, May 2006). Differentially expressed SNP alleles are coloured in black. The vertical bar above the horizontal line
means the SNP is on the forward strand, the one below means that it is on the reverse strand. SNP stretches with a p-value,0.00005 are highlighted
in blue boxes.
doi:10.1371/journal.pone.0004150.g001
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dbSD database.
dbSD Distance of a SNP to the closest SD
Inside 10 Kb 100 Kb 1 Mb
Out In Out In Out In Out In
No
ASGE
2160 39 2199 2103 57 2160 1667 436 2103 244 1423 1667
ASGE 2867 67 2934 2751 116 2867 2089 662 2751 243 1846 2089
5027 106 5133 4854 173 5027 3756 1098 4854 487 3269 3756
x
2 1.62 7.34 7.56 1.20
P 0.204 0.007 0.006 0.272
The distances represent the different windows of distance we considered
around each SNPs to test the effect of the proximity of a SD on ASGE. ‘‘In’’
means inside the windows of size considered.
doi:10.1371/journal.pone.0004150.t005
Table 6. Details of the permutation tests for the mean
absolute values of allelic gene expression ratios depending on
their position relatively to segmental duplications.
Windows Category n mean P
Inside Inside SD 106 2.1014
Outside 5027 1.5438 ,0.001
10 Kb Inside 10 Kb 173 1.6803
Outside 4854 1.5389 0.051
100 Kb Inside 100 Kb 1098 1.5724
Outside 3756 1.5292 0.183
1M b Inside 1 Mb 3269 1.5308
Outside 487 1.5183 0.776
Windows of sizes are the same as previously described.
doi:10.1371/journal.pone.0004150.t006
Table 7. Details of the chi-square tables and P-values for the
dbCNV database.
dbCNV Distance of a SNP to the closest CNV
Inside 10 Kb 100 Kb 1 Mb
Out In Out In Out In Out In
No
ASGE
1799 400 2199 1750 49 1799 1351 399 1750 182 1169 1351
ASGE 2410 524 2934 2355 55 2410 1896 459 2355 241 1655 1896
4209 924 5133 4105 104 4209 3247 858 4105 423 2824 3247
x
2 4.60 0.833 6.65 0.403
P 0.032 0.361 0.010 0.526
The distances represent the different windows of distance we considered
around each SNPs to test the effect of the proximity of a CNV on ASGE. ‘‘In’’
means inside the windows of size considered.
doi:10.1371/journal.pone.0004150.t007
Table 4. Mapping of SNPs.
Consequence type (Variation Feature) No. of SNPs available for analysis Differentially expressed SNPs % differentially expressed SNPs
No annotation 57 31 54
3Prime UTR 43 32 74
5Prime UTR 52 4 0
Downstream 119 76 64
Intergenic 2.455 1.190 48
Intronic 2.311 1.511 65
Non synonymous coding 14 12 86
Synonymous coding 26 20 77
Upstream 103 60 58
TOTAL 5.133 2.934 57
Despite we study poliadenilated RNA, intronic and intergenic SNPs also present ASGE. Thus, ncRNA display ASGE similar to that of known genes revealing even more
complexity in the system that regulates transcription.
doi:10.1371/journal.pone.0004150.t004
Table 8. Details of the permutation tests for the mean
absolute values of allelic gene expression ratios depending on
their position relatively to copy number variants from
databases.
Windows Category n mean P
Inside Inside SD 924 1.5934
Outside 4209 1.5469 0.213
10 Kb Inside 10 Kb 104 1.5162
Outside 4105 1.5477 0.771
100 Kb Inside 100 Kb 858 1.5724
Outside 3247 1.5292 0.080
1 Mb Inside 1 Mb 2824 1.5726
Outside 423 1.4928 0.138
Windows of sizes are the same as previously described.
doi:10.1371/journal.pone.0004150.t008
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results coming from the analysis of known SDs and CNVs are
largely consistent. Still, it may be surprising to see that the
association with ASGE is not identical for both databases. One
must take into account that the two datasets have different
properties. SDs are computationally defined from the Reference
Human Genome Assembly, whereas CNVs are structural variants
detected by experimental hybridizations. This means that the two
datasets are similar, but most certainly not identical. In addition, it
must be considered that individuals in this study are likely to
present a set of SDs and CNVs that only partially overlaps with
those present in public databases. Consequently, in the tests
conducted with information from public databases, we may have
mislabeled some SNPs, because a large number of structural
variations described in dbSD or dbCNV may not be present in the
20 individuals studied here.
Finally, we completed our study by focusing on the implications
of ASGE among ncRNA [18,19]. Thus, our current understand-
ing of the repertoire of transcripts produced from the human
genome is still evolving, further demonstrating the complexity of
the transcriptome. Indeed, the organization and structure of the
genome has potentially important implications for the regulation
of transcription and the possible interpretation of the naturally
occurring genetic variation in humans [24]. We found that
ncRNA display ASGE similar to that of known genes revealing
even more complexity in the system that regulates transcription.
In summary, ASGE is widespread across the human genome
and it participates in all biological processes, especially in the
regulation of gene expression in the immune system. If ASGE has
important implications in the genotype to phenotype relations and
in the regulation of complex interlaced transcriptional patterns, its
identification and characterization will provide a better under-
standing of the complexities of transcription regulation. Further-
more, such knowledge should allow us to focus on haplotypes with
allelic differences in expression that may be linked to complex
traits and common diseases.
Methods
Subjects
A total of 68 healthy Caucasian individuals were recruited to
this study. All of them were of Southern-European origin, which
minimize differences in population structure [25,26]. Twenty of
them, 12 male and 8 female, were used for the array screening
assays and the rest for the real time quantitative PCR validation.
The study was approved by the local ethical committee (IRB) and
patients provided written informed consent.
RNA and DNA purification and cDNA synthesis
Total RNA was extracted from peripheral blood mononuclear
cells (PBMCs). PBMCs were isolated from heparinized blood by
density gradient centrifugation using Ficoll-Paque (Pharmacia
Biotech). PBMCs were immediately submerged in the RNAlater
RNA Stabilization Reagent (Qiagen) to preserve their gene
expression patterns and total RNA was isolated using the RNeasy
Mini Kit (Qiagen). During RNA purification, DNA was removed
with a DNase treatment using the RNase-Free DNase Set
(Qiagen). Genomic DNA (gDNA) was isolated from granulocytes
obtained after density gradient centrifugation using the QIAamp
DNA Mini Kit (Qiagen). Synthesis of cDNA for the array
screening assays was performed on 2 mg of total RNA using a T7-
oligo dT12–18 primer (Amersham Pharmacia) and it was purified
using phenol:chloroform:isoamyl alcohol and NH4Ac precipita-
tion. The cDNA pellet was resuspended in 5 ml of reduced EDTA
TE buffer (10 mM Tris HCl, pH 8.0, 0.1 mM EDTA, pH 8.0).
Synthesis of cDNA for the real time quantitative PCR validation
was performed using the High-Capacity cDNA Archive Kit
(Applied Biosystems).
Mapping 10 K Array experiments
Genotyping and allele specific gene expression was assessed
using GeneChip Mapping 10 K Arrays (Affymetrix) according to
the manufacturer’s instructions using either 250 ng of gDNA or
Table 9. Details of the chi-square tables and P-values for the indCNV database.
dbSD Distance of a SNP to the closest indCNV
Inside 10 Kb 100 Kb 1 Mb
Out In Out In Out In Out In
No ASGE 9549 3 9552 9545 4 9549 9535 10 9545 9566 69 9635
ASGE 7522 4 7526 7518 4 7522 7503 15 7518 7370 52 7422
17071 7 17078 17063 8 17071 17038 25 17063 16936 121 17057
x
2 NA NA 2.58 0.014
P NA NA 0.11 0.905
dbSD Distance of a SNP to the closest indCNV
Up to 100 Kb
Out In
No ASGE 9535 17 9552
ASGE 7503 23 7526
17038 40 17078
x
2 2.93
P 0.086
The distances represent the different windows of distance we considered around each SNPs to test the effect of the proximity of a CNV on ASGE. ‘‘In’’ means inside the
windows of size considered.
doi:10.1371/journal.pone.0004150.t009
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by using the GeneChip DNA Analysis Software 2.0 (Affymetrix).
Allele expression data
A computational analysis of allele specific gene expression was
carried out as previously described [9]. Briefly, to be included in
our analysis, each SNP had to meet the following criteria: (1) at
least one out of twenty individuals must be heterozygous for the
SNP; and (2) the transcript containing the SNP must be expressed
in PBMCs. For the heterozygous SNPs, the intensity values for
each probe were extracted from the CEL files generated. The
value for each probe pair was calculated by subtracting the
mismatch (MM) intensity from the perfect match (PM) intensity. A
t test was used to calculate a p-value for the presence of signal for
each allele of each SNP (intensity greater than zero=expression
detected). The manufacturer defines a mini-block as a group of
four probes that include a PM and a MM probe for allele 1, and a
PM and a MM probe for allele 2. The Mapping 10 K Array
contains ten mini-blocks, 5 of which correspond to the forward
strand and the other five to the reverse strand. A signal was
considered if at least one allele developed a signal (p,0.01, t test)
in any of the strands. If a signal was only present in one strand, the
allele fraction (the ratio of expression of the two alleles) was
calculated only with the mini-blocks of the corresponding strand.
Thus, we quantified the ratio of expression of the two alleles for
the heterozygous SNPs present in transcripts expressed in PBMCs.
In order to obtain a statistical measure, the 99% confidence
interval for the allele ratio of gDNA (equivalent to equal
expression of the two alleles) was calculated for both alleles using
all the heterozygous SNPs in the 20 individuals. We obtained
ranges between 0.81 and 1.37. SNPs with differential allelic gene
expression were considered if the ratio of allele 1 to allele 2 fell
outside of the corresponding confidence interval.
The distribution of allele specific expression across the
genome
DNA-Chip Analyzer 2004 software [27] was used to map SNPs
to chromosomes and to look for clusters of differentially expressed
alleles of SNPs. To assess the significance of ‘‘SNP proximity’’, p-
values were calculated for all the stretches containing #20 SNPs
with differential allelic expression. Significant stretches of differ-
entially expressed SNPs were considered when the p-value,
0.00005.
[A paragraph has been removed from here]
Data about Segmental Duplication and Copy Number
Variations obtained from public databases
Copy Number Variation (CNV) and Segmental Duplication
(SD) data were obtained from publicly available databases and
were divided into two categories. The first one, that we called
‘‘dbCNV’’ was obtained at http://projects.tcag.ca/variation/, and
the second one called ‘‘dbSD’’ was downloaded from http://
eichlerlab.gs.washington.edu/database.html. For dbCNV, only
the studies based on large samples obtained from general
population were included, to avoid biasing our database towards
rare or disease-related variants. All coordinates were from build35
(hg17). On each independent database, we first filtered duplicates
out and then concatenated overlapping segments in order to form
a list of unique and excluding coordinate pairs representing
regions with SDs and/or CNVs. After these changes, the CNV
database presented 3,272 regions, distributed all over the genome.
The size of the CNV of this database ranged from 7,486,165 bp to
1,032 bp, with a mean size of 193,588 bp, and a standard
deviation of 394,728 bp. The SD database after modifications
showed 8,096 different duplications, with a size range from
875,877 bp to 999 bp, a mean size of 15,990 bp and a standard
deviation of 44,422 bp.
CNV detection in the samples
To detect CNVs in the samples, two technologies were used.
One was the Affymetrix GeneChipH Human Mapping 10 K
Array, covering 10,136 SNPs that had been used for the rest of the
analysis as explained above. The other one was the Agilent
G4410B array, a commercially available 60-mer oligonucleotide
microarray for CGH, with probes located in coding and non-
coding sequences at an average spatial resolution of 35 kb, and
where 44,887 probes were analyzed. For this second array, we
hybridized the samples following the manufacturer’s protocol (v2),
in dye-swap experiments against a reference pool from the same
gender. Reference samples consist in a pool of 50 normal
individuals from the same gender. In brief, 1000 ng of DNA
was digested with 5 units of Alu I and Afa I (GE Healthcare)
during 2 hours at 37u. After inactivating the enzymes 20 minutes
at 65uC, the DNA was labeled using the Bioprime arrayCGH
Labeling kit (Invitrogen). 20 ml of 2.56Random Primer solution
was added and incubated 5 min at 95u followed by 5 min in ice.
Then 5 mlo f1 0 6dNTP mix were added as well as 3 mlo f1m M
dUTP-Cy3 or dUTP-Cy5 (GE Healthcare) and 40 U of Klenow
fragment (Invitrogen). The reaction was incubated 2 hours at 37u
and was cleaned up using Microcons YM-30 (Millipore). 1.5 mlo f
the labeled DNA was used to check for the incorporation of
fluorescent nucleotide incorporation using a Nanodrop instru-
ment. Then test sample and reference were mixed together with
50 mlo f1 0 6 Blocking Agent (Agilent), 50 mg of human Cot-1
(Roche) and 250 mlo f2 6Hybridization buffer (Agilent). A
denaturation step was performed during 3 min at 95u followed
by an incubation of 30 min at 37u before hybridization. Arrays
were hybridized during 40 at 65u in a hybridization oven rotating
at 10 rpm. Arrays were washed 5 min in oligo aCGH wash buffer
1 (Agilent) at RT, 1 min in oligo aCGH wash buffer 2 (Agilent) at
37u, 30 sec in actonitrile (Sigma) at RT and 30 sec in stabilizing
and drying solution (Agilent) at RT to prevent ozone degradation.
All washes were performed with agitation using a magnetic stir.
Arrays were scanned using an Agilent G2565BA MicroArray
Scanner System (Agilent Inc., Palo Alto, Ca) and the acquired
images were analyzed using GenePix Pro 6.0 software (Axon,
Molecular Devices) using the irregular feature finding option.
Extracted raw data was filtered and Loess normalized using
Bacanal (Lozano et a., unpublished), an in house web server
implementation of the Limma package developed within the
Bioconductor project in the R statistical programming environ-
ment.
CNV-detection algorithm
The data were analyzed with the R software [28]. Data
obtained from both technologies (10 K and 44 K arrays) were
analyzed separately. In both cases, the standard deviation of the
mean log2 values for autosomes were calculated for all the
individuals and the distribution of these values was plotted.
Individuals for which standard deviations were below 0.18 and for
which the distribution of the log2 values was symmetrical with
respect to 0 were selected for a first analysis. In this first analysis,
we wrote a R script that looks for two consecutive clones or 3 out
of 4 consecutive clones that would have log2 ratios above a
multiple of the standard deviation of the whole individual. Then,
the script checks for consistency with dye-swap data, and only
keeps the regions that are also called in the dye-swap experiment.
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adapted to cases where data are dispersed or if there are local
trends in the data. This is why only data of 18 individuals obtained
with the 44 K array were analyzed with the first method. R
functions designed to deal with these problems were applied to the
part of the dataset that did not match the criteria for the first
analysis. The second analysis was applied to all the individuals
(including those that were analyzed in the first analysis), and was
done as follows. First, the normalized log ratios from each dye-
swap were averaged before the analysis. Then, a denoising step
was applied using the method described in Hsu et al. [29] using
the Haar wavelet family and the sure estimator for thresholding,
with Jo (the level up to which the wavelet coefficients are subject to
thresholding) equals to 4. The wavelet decomposition and
reconstruction functions were from the WAVESLIM package.
Finally, the Circular Binary Segmentation algorithm described in
Olshen et al [30] was used for clone calling. For this purpose, the
functions CNA, smooth. CNA and segment, available in the
DNAcopy package, were used with default parameter values. Data
from the two analyses were combined. The second analysis
method is, overall, more conservative, but has the ability to rescue
some regions that would not pass the very strict threshold based on
standard deviation. Consequently, the overlap between the regions
called with the two methods is large, but not complete. This is why
the clones that were called by only one method were manually
checked in the data file for validity of signal. At the end of the BAC
call process, regions of more than 1 Mb were removed from the
list. The final list was constituted by 294 calls (an average of 14.7
per individual). The data obtained through this process are
individual CNV coordinates and we subsequently refer to them as
‘‘indCNV’’.
Allele-specific gene expression analysis
The most characteristic GO term for each cluster was Assigned
using FatiGO [31]. The list of imprinted genes was obtained from
the Genomic Imprinting Database (http://www.geneimprint.
com/).
Real-time quantitative PCR validation
Quantitative real-time PCR analysis was performed with a
DNA Engine Opticon2 (MJ Research). Primer sequences and
target-specific fluorescent labeled TaqMan probes used for both
genotyping and allele-specific gene expression were purchased
from Applied Biosystems (TaqMan SNP Genotyping Assays). PCR
reactions were prepared following the manufacturer’s protocol.
Genotype calls were acquired with Opticon Monitor 2.01 software
(MJ Research) and allele-specific gene expression was measured as
described previously [9]. In short, 48 individuals were genotyped
for each SNP by real time PCR. We selected eight heterozygous
individuals for each SNP for allelic to validate expression. Allele-
specific gene expression was measured in these 8 individuals by
real time PCR. A standard curve (linear regression line) was
generated for each SNP mixing gDNAs from two homozygous
individuals at ratios 8:1, 4:1, 2:1, 1:1, 1:2, 1:4 and 1:8, one for each
genotype. To check that standard curves were generated with truly
homozygous individuals four of them were sequenced for three
SNPs confirming the homozygosis. Each sample was run in
triplicate, and cycle threshold (c(t)) values were obtained with
Opticon Monitor 2.01 software. Using this information we
subtracted the baseline signal as the lowest fluorescent signal
measured, and we set the c(t) line to a standard deviation of 0.1.
The log of FAM mean c(t)/VIC mean c(t) values were plotted
against the log of the gDNA ratio. The linear graphs obtained
(correlation coefficients .0.9) were used to calculate the
corresponding allele-specific gene expression. The 99% confidence
interval for the allele-specific gene expression (equivalent to equal
expression) was generated from heterozygous DNAs. SNPs with
allele-specific gene expression outside of the corresponding
confidence interval were considered significant.
Statistical tests
On all the datasets (dbCNV, SD and indCNV), we tested the
association between SNPs with significant ASGE and proximity of
a CNV by the means of Chi-square tests. To this purpose, we
wrote a series of PHP scripts to check whether each SNP was
located within a SD/CNV, between 1 bp and 10 Kb upstream or
downstream a SD/CNV, between 10 Kb and 100 Kb upstream
or downstream a SD/CNV or between 100 Kb and 1 Mb
upstream or downstream a SD/CNV. When a SNP could belong
to two different SD/CNVs, we always exclusively considered the
shortest distance. No SNP could therefore belong to two SDs or
two CNVs, or could be included in two different categories of
distance in the same SDs or CNVs.
For data obtained from public databases, we crossed the
positions of the dbSD and dbCNVwith those of the 5,133 SNP
that were heterozygous in at least one individual. For the
individual data, instead of using the 5,133 SNP, we used only
the ones that were heterozygous in the individual we were testing,
and instead of using public database, we used the results of the
10 K and 44 K hybridization data. That is, we crossed the
individual information of indCNV for a given individual and its
own heterozygous SNPs. In this analysis, we therefore generated
20 tables for each of the distance windows we considered. Because
very few indCNV were detected in the individual analysis, each
contingency table had small sample sizes. To overcome this
problem, we performed single Chi-square tests on synthetic tables
built for each distance window, in which numbers in each cell
represented the cumulate sample size of the 20 individuals for the
corresponding category, previously obtained in the 20 individual
tables. In the analysis of indCNV, in order to overcome problems
of sample size, we also considered a window of distance that would
include all SNP from inside up to 100 K upstream and
downstream of a CNV.
In addition to Chi-square tests, we also performed permutation
tests for each window of size, to assess whether the ratio of allele
expression was the same inside or outside the distance considered.
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